These findings indicate that LXRβ is abnormally expressed in GC tissues from patients, which is consistent with the findings of a previous report.5 In pancreatic cancer, LXRβ can be detected in pancreatic adenoma clinical samples and in all pancreatic cell lines.5 LXRβ expression during disease stage I or II was also statistical significance (Table 1), suggesting that LXRβ may be a potential target during the early stage of gastric cancer. The gene discussed is NR1H2; the disease is gastric cancer.